<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00963404</url>
  </required_header>
  <id_info>
    <org_study_id>CIRRO IP 070109 DaBlaCa-1</org_study_id>
    <secondary_id>M-20080210</secondary_id>
    <nct_id>NCT00963404</nct_id>
  </id_info>
  <brief_title>Image-Guided Tumorboost of Bladder Cancer</brief_title>
  <official_title>Image-guided Tumorboost of Localized Unifocal Bladder Cancer: A Phase I/II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to increase the radiation dose (Boost) to the bladder tumor. The
      bladder cancer patients included in the study will undergo tumor demarcation. The bladder
      demarcations will then be the target for an image-guided boost delivered precisely to the
      expected tumor site.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local tumor control</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute and late adverse effects of the radiotherapy treatment</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Bladder Neoplasms</condition>
  <arm_group>
    <arm_group_label>Tumor-boost</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Image-guided tumorboost of the bladder cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation boost</intervention_name>
    <description>Radiation boost of the bladder-tumor: 10 Gy/5 fractions, 2 Gy per fraction.</description>
    <arm_group_label>Tumor-boost</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Muscle invasive bladder cancer (transitional carcinoma)

          -  Unifocal

          -  TNM stage T2a-4a, N0-1, M0

          -  unfit for radical cystectomy

        Exclusion Criteria:

          -  Hyperthyroidism

          -  Multinodular goiter

          -  Pregnancy

          -  Breast feeding

          -  WHO preformance status more than 2

          -  Iodine allergy

          -  MRI or CT contrast media allergy

          -  Bi-lateral hip-prosthesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jimmi Sondergaard</last_name>
    <role>Principal Investigator</role>
    <affiliation>The department of Oncology, Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The department of Oncology, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>Dk-8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The department of Oncology, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>Dk-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The department of Oncology, Herlev University Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>Dk-2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The department of Oncology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>Dk-5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.cirro.dk</url>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2009</study_first_submitted>
  <study_first_submitted_qc>August 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2009</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Image-guided Radiotherapy</keyword>
  <keyword>Fiducial marker</keyword>
  <keyword>Adverse effects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

